We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

106 hedge funds and large institutions have $397M invested in Cullinan Oncology in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 30 increasing their positions, 38 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $330M → $397M (+$67.8M)

15% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 20

11.67% more ownership

Funds ownership: 82.04% → 93.7% (+12%)

3% more funds holding

Funds holding: 103 → 106 (+3)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

21% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 38

89% less call options, than puts

Call options by funds: $43K | Put options by funds: $390K

Holders
106
Holders Change
+3
Holders Change %
+2.91%
% of All Funds
1.66%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
30
Reduced
38
Closed
20
Calls
$43K
Puts
$390K
Net Calls
-$347K
Net Calls Change
-$361K

Top Buyers

Rank Fund Capital Flow
1
B
Braidwell
Connecticut
+$20.3M
2
Franklin Resources
Franklin Resources
California
+$16.4M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$12.2M
4
Citadel Advisors
Citadel Advisors
Florida
+$4.6M
5
Verition Fund Management
Verition Fund Management
Connecticut
+$2.35M

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$5.6M
2
SCM
Silverarc Capital Management
Massachusetts
-$2.71M
3
EC
EcoR1 Capital
California
-$2.52M
4
BlackRock
BlackRock
New York
-$1.61M
5
AI
Atom Investors
Texas
-$1.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
26
Bank of Montreal
Ontario, Canada
$2.48M +$1.99M +187,547 New
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$2.42M +$1.59M +150,000 +200%
Verition Fund Management
28
Verition Fund Management
Connecticut
$2.38M +$2.35M +221,111 New
Millennium Management
29
Millennium Management
New York
$2.03M -$589K -55,480 -23%
Charles Schwab
30
Charles Schwab
California
$2M -$18.6K -1,747 -0.9%
Assenagon Asset Management
31
Assenagon Asset Management
Luxembourg
$1.37M -$1M -94,468 -43%
LCM
32
Lynx1 Capital Management
Puerto Rico
$1.24M +$1.22M +115,063 New
SSA
33
Schonfeld Strategic Advisors
New York
$1.13M +$751K +70,700 +206%
Goldman Sachs
34
Goldman Sachs
New York
$1.09M -$833K -78,393 -44%
UBS Group
35
UBS Group
Switzerland
$980K -$106K -9,985 -10%
Bank of New York Mellon
36
Bank of New York Mellon
New York
$938K -$96.3K -9,070 -9%
UOC
37
UBS O'Connor
Illinois
$915K +$903K +85,000 New
Jacobs Levy Equity Management
38
Jacobs Levy Equity Management
New Jersey
$901K +$890K +83,745 New
N
39
Nuveen
North Carolina
$832K +$54.2K +5,103 +7%
AQR Capital Management
40
AQR Capital Management
Connecticut
$773K -$175K -16,470 -19%
VRS
41
Virginia Retirement Systems
Virginia
$697K +$30.8K +2,900 +5%
Ameriprise
42
Ameriprise
Minnesota
$676K +$32.2K +3,034 +5%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$602K -$187K -17,627 -24%
Fidelity Investments
44
Fidelity Investments
Massachusetts
$591K +$6.9K +650 +1%
Jane Street
45
Jane Street
New York
$580K +$342K +32,196 +148%
VCIM
46
Velan Capital Investment Management
Georgia
$538K +$531K +50,000 New
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$497K -$51.7K -4,866 -10%
AllianceBernstein
48
AllianceBernstein
Tennessee
$471K +$117K +11,040 +34%
MAM
49
Martingale Asset Management
Massachusetts
$458K – – –
NYLIM
50
New York Life Investment Management
New York
$433K -$38.4K -3,618 -8%
1
2
3 4 5

CGEM Hedge Fund Activity: Q2 2023 in Review

106 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q2 2023, worth a combined $397M — up 21% from $330M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CGEM positions and 20 closed out — a net gain of 3 holders — while 30 added to existing stakes and 38 trimmed.

The largest buyer was Braidwell, opening a new position worth an estimated $20.3M. The largest seller was Vanguard Group, cutting an estimated $5.6M.

  • 106 institutional investors held Cullinan Oncology (CGEM) as of Q2 2023, up from 103 in Q1 2023.
  • Funds reported $397M of Cullinan Oncology stock for Q2 2023, up 21% quarter-over-quarter.
  • 23 funds opened new Cullinan Oncology positions in Q2 2023 and 20 closed out, a net change of +3 holders.
  • The largest Cullinan Oncology buyer in Q2 2023 was Braidwell, an estimated $20.3M added.
  • The largest Cullinan Oncology seller in Q2 2023 was Vanguard Group, an estimated $5.6M sold.

Based on aggregated 13F filings for Q2 2023.